Market closed

ICU Medical/$ICUI

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About ICU Medical

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Ticker

$ICUI
Trading on

Industry

Health Care Equipment & Supplies

Employees

14,000

ICU Medical Metrics

BasicAdvanced
$4.1B
Market cap
-
P/E ratio
-$4.57
EPS
0.66
Beta
-
Dividend rate
$4.1B
0.66
$181.06
$82.82
217K
2.289
0.914
75.337
77.826
0.43%
0.66%
-5.35%
1.74
2
-19.02
25.527
4.04%
291.82%
21.76%
-3.15%

What the Analysts think about ICU Medical

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ICU Medical stock.

ICU Medical Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ICU Medical Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ICUI

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ICU Medical stock?

ICU Medical (ICUI) has a market cap of $4.1B as of November 22, 2024.

What is the P/E ratio for ICU Medical stock?

The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of November 22, 2024.

Does ICU Medical stock pay dividends?

No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next ICU Medical dividend payment date?

ICU Medical (ICUI) stock does not pay dividends to its shareholders.

What is the beta indicator for ICU Medical?

ICU Medical (ICUI) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.